Lipoprotein lipase deficiency many of the patients. Lipid lowering drugs Lipid-lowering agents such as fibrates and omega-3-fatty acids can be used to lower TG levels in LPLD; however, those drugs are very often not effective enough to reach treatment goals in LPLD patients. Statins should be considered to lower elevated non-HDL-Cholesterol. Additional measures are avoidance of agents known to increase endogenous triglyceride levels, such as alcohol, estrogens, diuretics, isotretinoin, anidepressants (e.g. sertraline) and b-adrenergic blocking agents. Gene therapy In 2012, the European Commission approved alipogene tiparvovec (Glybera), a gene therapy for adults diagnosed with familial LPLD (confirmed by genetic testing) and suffering from
What Degree? Which University? their studying experiences. Handley resurrected the concept in 2010 with the help of a team of undergraduate students, and launched "What Degree? Which University?" as a website in August 2011. Six months after its launch, "What Degree? Which University?" had attracted more than 22,000 visitors and expanded to provide information about universities across Australia. Today, the website covers 23 Australian universities and is staffed by 17 undergraduate and postgraduate students Australia-wide, who manage and produce the content for the site. "What Degree? Which University?" claims to have had 77,500 visits to the website (55,000 of which being unique visitors) and